BIIB

Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral sclerosis; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE.

Biogen Inc. (BIIB) is a healthcare company listed on Nasdaq, traded in USD. Over the past year it moved between $148.51 and $258.78.

• Healthcare
• Drug Manufacturers - General
• Cambridge, United States
• 7.5K employees
• Led by Christopher A. Viehbacher